{
    "testId": 396302709,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 109,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 4,
    "questionModeName": "CUSTOM",
    "testName": "",
    "totalQuestionCorrect": 5,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 721,
    "averageTimeSpentInSeconds": 114,
    "otherAverageTimeSpentInSeconds": 69,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 11,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "4",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 17083,
            "questionIndex": 18534,
            "questionText": "<p>A 37-year-old woman, gravida 1 para 0, at 37 weeks gestation comes to the emergency department due to severe epigastric pain.&nbsp; The pain started yesterday and has progressively worsened.&nbsp; She developed nausea today but has had no fever, vomiting, or diarrhea.&nbsp; The patient has no contractions, leakage of fluid, or vaginal bleeding.&nbsp; Fetal movement is normal.&nbsp; She has no chronic medical conditions and has had no surgeries.&nbsp; Temperature is 37.3 C (99.1 F), blood pressure is 168/94 mm Hg, and pulse is 98/min.&nbsp; BMI is 29 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Fetal heart tones are 140/min.&nbsp; The patient appears anxious and in moderate distress.&nbsp; The abdomen is tender in the epigastrium with no rebound, rigidity, or guarding.&nbsp; The uterus is gravid and nontender.&nbsp; Urinalysis shows 3+ protein.&nbsp; Ultrasound of the right upper quadrant is normal.&nbsp; This patient is at increased risk for developing which of the following complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t40818\"><table class=\"table-default-style table-header-footer-style\" style=\"width:614px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Preeclampsia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Nulliparity</li><li>Obesity</li><li>Preexisting medical condition (eg, SLE, chronic hypertension)</li><li>Multiple gestation</li><li>Advanced maternal age</li></ul></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>New-onset hypertension* (SBP &ge;140 or DBP &ge;90&nbsp;mm&nbsp;Hg)<br />at &ge;20&nbsp;weeks</li></ul><p style=\"margin-left:.25in;\">&nbsp; &nbsp; &nbsp;AND</p><ul><li>Proteinuria OR signs/symptoms of other end-organ damage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Severe features</strong></p></td><td><ul><li>Severe-range hypertension (SBP &ge;160 or DBP &ge;110&nbsp;mm&nbsp;Hg)</li><li>Platelets &lt;100,000/mm<sup>3</sup></li><li>Creatinine &gt;1.1 mg/dL or 2x normal</li><li>Elevated transaminases &gt;2x upper limit of normal</li><li>Pulmonary edema</li><li>Vision&nbsp;or cerebral symptoms (eg, headache)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>&lt;37 weeks &amp; no severe features: expectant</li><li>&ge;37 weeks (or &ge;34&nbsp;weeks with severe features): delivery</li><li>Severe-range blood pressure: IV labetalol, IV hydralazine,<br />PO nifedipine</li><li>Seizure prophylaxis: magnesium sulfate</li></ul></td></tr><tr><td colspan=\"2\"><p>*On 2 measurements &ge;4 hr apart.</p><p><strong>DBP</strong>&nbsp;=&nbsp;diastolic blood pressure; <strong>IV</strong>&nbsp;=&nbsp;intravenous; <strong>PO</strong>&nbsp;=&nbsp;by mouth; <strong>SBP</strong>&nbsp;=&nbsp;systolic blood pressure; <strong>SLE</strong>&nbsp;=&nbsp;systemic lupus erythematosus.</p></td></tr></tbody></table></div><p>This patient with new-onset epigastric pain, hypertension, and proteinuria at 37 weeks gestation has <strong>preeclampsia with severe features</strong>, a potentially life-threatening condition.&nbsp; Preeclampsia is most likely caused by abnormal placentation and narrowed spiral artery formation.&nbsp; The resulting placental hypoperfusion, hypoxia, and ischemia trigger the release of antiangiogenic factors causing maternal <strong>endothelial cell damage</strong>.</p><p>This damage may manifest in multiple organ systems, including the liver (eg, referred epigastric pain from stretching of the hepatic capsule) and kidneys (eg, proteinuria from acute kidney injury).&nbsp; In the brain, endothelial cell damage can precipitate an <strong>acute stroke</strong> via the following mechanisms:</p><ul><li><p>Activation of the coagulation system, platelet aggregation, and <strong>vascular microthrombi formation</strong>, leading to cerebral vessel occlusion (ischemic stroke).</p></li><li><p>Dysregulated cerebral blood flow that causes inappropriate cerebral vasospasm, severely elevated perfusion pressure, and ruptured intracerebral vessels (hemorrhagic stroke).</p></li></ul><p>To decrease these risks, patients with severe-range hypertension (ie, systolic &#8805;160 or diastolic &#8805;110 mm Hg) require prompt antihypertensive therapy (eg, IV labetalol, IV hydralazine).&nbsp; Treatment of preeclampsia with severe features is with delivery because removal of the placenta is typically curative.</p><p><strong>(Choice B)</strong>&nbsp; The primary risk factor for ascending cholangitis is biliary calculi, which can present with epigastric pain and nausea.&nbsp; However, this patient&#39;s ultrasound of the right upper quadrant is normal.</p><p><strong>(Choice C)</strong>&nbsp; Patients with increased intraesophageal pressure (eg, vomiting) are at risk for Boerhaave syndrome (ie, effort rupture of the esophagus).&nbsp; This patient has had no vomiting.</p><p><strong>(Choice D)</strong>&nbsp; The risk of intraamniotic infection is increased in patients with prolonged rupture of membranes.&nbsp; This patient has had no leakage of fluid.</p><p><strong>(Choice E)</strong>&nbsp; Subarachnoid hemorrhage typically occurs due to a ruptured intracranial saccular (berry) aneurysm; risk factors include cigarette smoking and chronic hypertension, which are not seen in this patient.&nbsp; Preeclampsia is not a risk factor.</p><p><strong>Educational objective:</strong><br>Preeclampsia with severe features increases the risk of acute stroke due to endothelial cell damage, dysregulation of cerebral blood flow, cerebral vasospasm, and vascular microthrombi formation, particularly in patients with severe hypertension (ie, systolic &#8805;160 or diastolic &#8805;110 mm Hg).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute ischemic stroke",
                    "choiceNumber": 1,
                    "correctTaken": 8622,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ascending cholangitis",
                    "choiceNumber": 2,
                    "correctTaken": 1665,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Boerhaave syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 807,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intraamniotic infection",
                    "choiceNumber": 4,
                    "correctTaken": 1054,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subarachnoid hemorrhage",
                    "choiceNumber": 5,
                    "correctTaken": 4555,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21331336",
                    "mediaDataId": 0,
                    "title": "Ischemic stroke during pregnancy and puerperium.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21331336",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29438078",
                    "mediaDataId": 0,
                    "title": "Preeclampsia: association with posterior reversible encephalopathy syndrome and stroke.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29438078",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24431615",
                    "mediaDataId": 0,
                    "title": "Cerebrovascular complications in pregnancy and puerperium.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24431615",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 101,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 16703,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 101,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 4892,
            "questionIndex": 4892,
            "questionText": "<p>A 33-year-old woman, gravida 2 para 2, is evaluated 5 days after an emergency cesarean delivery that was performed for fetal distress.&nbsp; Her postoperative course has been complicated by endometritis that is currently being treated with intravenous gentamicin and clindamycin.&nbsp; The patient received no prenatal care during this pregnancy and came to the hospital in active labor.&nbsp; She would like to breastfeed but had difficulty breastfeeding her first child and switched to formula at 6 weeks postpartum, after she developed lactational mastitis.&nbsp; The patient uses cocaine several times a week.&nbsp; Temperature is 36.7 C (98 F) and blood pressure is 110/60 mm Hg.&nbsp; Admission laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Urine drug screen</td><td style=\"vertical-align:middle;\">cocaine</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B surface antigen</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B core antibody, IgM</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B core antibody, IgG</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B surface antibody</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B virus DNA</td><td style=\"vertical-align:middle;\">undetectable</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis C virus antibody</td><td style=\"vertical-align:middle;\">positive</td></tr></tbody></table><p>After delivery, the infant received both hepatitis B immunoglobulin and the hepatitis B vaccination.&nbsp; Which of the following is a contraindication to breastfeeding in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31825\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Breastfeeding contraindications</strong></p></td></tr><tr><td><p align=\"center\"><strong>Maternal</strong></p></td><td><ul><li>Active untreated tuberculosis</li><li>HIV infection*</li><li>Herpetic breast lesions</li><li>Active varicella infection</li><li>Chemotherapy or radiation therapy</li><li>Active substance use disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Infant</strong></p></td><td><ul><li>Galactosemia</li></ul></td></tr><tr><td colspan=\"2\"><p>*In developed countries where formula is readily available.</p></td></tr></tbody></table></div><p>Breast milk is recommended as the exclusive source of nutrition for infants age &lt;6 months due to infant and maternal health benefits.&nbsp; Compared with formula feeding, infant benefits include improved nutrition, gastrointestinal function, host defense, and psychological well-being.&nbsp; Maternal benefits include accelerated recovery from pregnancy, weight loss, prolonged postpartum anovulation, and decreased risk of breast and ovarian cancer.</p><p>Despite its advantages, breastfeeding is contraindicated in certain maternal and infant conditions.&nbsp; Maternal <strong>contraindications to breastfeeding</strong> include active untreated tuberculosis, varicella infection, herpetic breast lesions, current chemotherapy, and <strong>active substance use</strong> (eg, cocaine, phencyclidine).&nbsp; Cocaine passes into breast milk and may cause <strong>infant intoxication and withdrawal</strong> symptoms (eg, irritability, tremors).&nbsp; In addition, cocaine may cause <strong>long-term neurobehavioral problems</strong> (eg, hyperactivity, cognitive delay).</p><p>Galactosemia, caused by impaired infant galactose metabolism, is the only absolute contraindication to breastfeeding that is neonatal in origin.&nbsp; Infants with other inborn errors of metabolism may breastfeed intermittently but require close monitoring of metabolite levels.</p><p><strong>(Choices B and C)</strong>&nbsp; Although hepatitis C viral RNA is detectable in maternal colostrum, transmission of hepatitis C via breast milk has not been documented.&nbsp; Infants of mothers with hepatitis B can safely breastfeed if administration of the hepatitis B immunoglobulin and initiation of the hepatitis B vaccination series has occurred.&nbsp; It is recommended that mothers with hepatitis B and C breastfeed.&nbsp; However, they should abstain from breastfeeding if their nipples are cracked or bleeding.</p><p><strong>(Choice D)</strong>&nbsp; Neither a history of mastitis nor active mastitis is a contraindication to breastfeeding.&nbsp; Women with mastitis who are in too much discomfort to breastfeed can either pump or manually express their breast milk.</p><p><strong>(Choice E)</strong>&nbsp; Gentamicin is poorly distributed into breast milk and is safe during lactation.&nbsp; Clindamycin is excreted into breast milk but is not associated with adverse neonatal effects; therefore, it is not contraindicated.</p><p><strong>Educational objective:</strong><br>Breastfeeding is the recommended source of nutrition for infants age &lt;6 months.&nbsp; However, there are contraindications to breastfeeding that include active untreated tuberculosis, varicella infection, herpetic breast lesions, current chemotherapy, and active substance use (eg, cocaine, phencyclidine).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 17731,
            "topic": "Breastfeeding",
            "titleId": 17731,
            "title": "Breastfeeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Active substance use",
                    "choiceNumber": 1,
                    "correctTaken": 13281,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis B",
                    "choiceNumber": 2,
                    "correctTaken": 1447,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis C",
                    "choiceNumber": 3,
                    "correctTaken": 1359,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "History of mastitis",
                    "choiceNumber": 4,
                    "correctTaken": 89,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous antibiotics",
                    "choiceNumber": 5,
                    "correctTaken": 721,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20130780",
                    "mediaDataId": 0,
                    "title": "Cannabis and breastfeeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20130780",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21536948",
                    "mediaDataId": 0,
                    "title": "Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21536948",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22371471",
                    "mediaDataId": 0,
                    "title": "Breastfeeding and the use of human milk.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22371471",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 168,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 16897,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 168,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 11093,
            "questionIndex": 12235,
            "questionText": "<p>A 32-year-old primigravida at 18 weeks gestation is evaluated in the emergency department for increasing confusion and incoherence.&nbsp; Her husband says that she has become increasingly unsteady while standing and has fallen twice.&nbsp; The patient was previously seen in the emergency department for nausea and vomiting and was treated with intravenous fluids and antiemetics.&nbsp; Although she continues to take oral antiemetics, she has had persistent vomiting and has lost 7 kg (15.4 lb) of her prepregnancy weight.&nbsp; Blood pressure is 110/60 mm Hg and pulse is 98/min.&nbsp; Fetal heart tones are 155/min.&nbsp; Physical examination shows nystagmus but no scleral icterus.&nbsp; Pupils are equal and reactive to light and accommodation.&nbsp; Abdominal examination shows epigastric pain but no rebound or involuntary guarding.&nbsp; The patient has trace pedal edema over her bilateral lower extremities and bilaterally absent ankle reflexes.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td>36%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td>84 fL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>240,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>10,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>131 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.2 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td>90 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>36 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>18 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>70 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td>110 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td>114 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Lipase</td><td>32 U/L</td></tr></tbody></table><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36164\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Wernicke encephalopathy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Associated conditions</strong></p></td><td><ul><li>Chronic alcohol use (most common)</li><li>Malnutrition (eg, anorexia nervosa)</li><li>Hyperemesis gravidarum</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Thiamine deficiency</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Encephalopathy</li><li>Oculomotor dysfunction (eg, horizontal nystagmus &amp; bilateral abducens palsy)</li><li>Postural &amp; gait ataxia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Intravenous thiamine followed by glucose infusion</li></ul></td></tr></tbody></table></div><p>This patient&#39;s presentation of <strong>altered mental status</strong> (eg, encephalopathy), oculomotor dysfunction (eg, <strong>nystagmus</strong>), and <strong>gait ataxia</strong> are suggestive of <strong>Wernicke encephalopathy</strong> (WE), a neurological disease due to a thiamine deficiency.&nbsp; Although most commonly associated with alcoholism, WE can also occur with <strong>hyperemesis gravidarum</strong> (HG), a severe, persistent nausea and vomiting of pregnancy that results in weight loss and dehydration.</p><p>Patients with HG commonly have <strong>hypochloremic metabolic alkalosis</strong>, hypokalemia, <strong>hypoglycemia</strong>, and <strong>elevated serum aminotransferases</strong>, all of which occur as the result of protracted vomiting.&nbsp; Treatment for this patient should include antiemetics, fluids, and thiamine supplementation.&nbsp; Patients with HG often require glucose infusions due to prolonged hypoglycemia.&nbsp; However, glucose infusion prior to thiamine supplementation can exacerbate WE and should be delayed until the patient has received thiamine.&nbsp; WE in pregnancy is associated with an increased risk of spontaneous abortion; thiamine supplementation may decrease this risk.</p><p><strong>(Choice A)</strong>&nbsp; Acute fatty liver of pregnancy can present with nausea, vomiting, elevated serum aminotransferases, and hypoglycemia but typically occurs in the third trimester.&nbsp; At 18 weeks gestation, this diagnosis is unlikely.</p><p><strong>(Choice B)</strong>&nbsp; HELLP syndrome can present with nausea, vomiting, and elevated serum aminotransferases.&nbsp; However, HELLP syndrome also requires low platelets and evidence of hemolysis for diagnosis, which are not seen in this patient.&nbsp; Physical examination findings include hyperreflexia rather than absent reflexes.</p><p><strong>(Choice C)</strong>&nbsp; Late neurosyphilis manifests years after an initial syphilitic infection and is characterized by tabes dorsalis (eg, sensory ataxia, lancinating pain) and Argyll Robertson pupils (eg, normal pupillary constriction with accommodation but not light).&nbsp; This patient has a normal pupillary examination and an acute presentation.</p><p><strong>(Choice E)</strong>&nbsp; Vitamin B12 deficiency presents with dementia and a subacute combined degeneration due to demyelination of spinocerebellar tracts (eg, gait ataxia), lateral corticospinal tracts (eg, spastic paresis), and dorsal columns (eg, loss of position and vibration sense).&nbsp; However, the clinical course of vitamin B12 deficiency is indolent rather than acute.&nbsp; Patients also have a macrocytic anemia (mean corpuscular volume &gt;100 fL).</p><p><strong>Educational objective:</strong><br>Wernicke encephalopathy is a complication of hyperemesis gravidarum that results from thiamine deficiency.&nbsp; Classic presenting symptoms include encephalopathy, oculomotor dysfunction, and gait ataxia.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 9182,
            "topic": "Thiamine deficiency",
            "titleId": 9182,
            "title": "Thiamine deficiency",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute fatty liver of pregnancy",
                    "choiceNumber": 1,
                    "correctTaken": 4865,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HELLP syndrome",
                    "choiceNumber": 2,
                    "correctTaken": 916,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Late neurosyphilis",
                    "choiceNumber": 3,
                    "correctTaken": 1030,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thiamine deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 8751,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin B<font size=\"2\"><sub>12</sub></font> deficiency",
                    "choiceNumber": 5,
                    "correctTaken": 1231,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 156,
            "othersAvgTimeSpent": 96,
            "notes": null,
            "peopleTaken": 16793,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 156,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 14280,
            "questionIndex": 15688,
            "questionText": "<p>A 28-year-old primigravida was admitted to the hospital in active labor.&nbsp; On admission, her cervix was 7 cm dilated and 100% effaced.&nbsp; She received epidural anesthesia and proceeded to complete cervical dilation with the fetal head at +3 station within a few hours.&nbsp; The patient has been pushing for 4 hours and is exhausted.&nbsp; She cannot feel her contractions and does not know when to push because of her epidural anesthesia.&nbsp; The patient has had no complications during the pregnancy and has no chronic medical conditions.&nbsp; The estimated fetal weight by Leopold maneuvers is 3.4 kg (7.5 lb).&nbsp; Vital signs are normal.&nbsp; Fetal heart rate tracing is category 1.&nbsp; Tocodynamometer indicates contractions every 2-3 minutes.&nbsp; A repeat cervical examination shows complete cervical dilation with the fetal head at +3 station and in the left occiput anterior position with no molding or caput.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"22399\" src=\"https://www.uworld.com/media/L48832.jpg\" ></p><p>The <strong>second stage of labor</strong> is the period from complete cervical dilation <strong>(10 cm) to fetal delivery</strong>.&nbsp; This patient achieved excellent fetal descent to +3 due to her average-sized infant (eg, 3.4 kg), suitable pelvis (no fetal molding or caput, suggesting no resistance against the bony maternal pelvis), and favorable fetal position (left occiput anterior).&nbsp; However, she meets criteria for <strong>second-stage arrest</strong> (ie, no further fetal descent), which are:</p><ul><li>&#8805;3 hours of pushing in a <strong>primigravida</strong> without an epidural; some providers allow additional time with an epidural (ie, <strong>&#8805;4 hours pushing</strong> with an epidural, as in this patient)</li></ul><p>OR</p><ul><li>&#8805;2 hours of pushing in a multigravida without an epidural (&#8805;3 hours pushing with an epidural)</li></ul><p>Continued pushing <strong>increases delivery complications</strong> (eg, postpartum hemorrhage) with limited chance of spontaneous vaginal delivery.&nbsp; Therefore, the best next step in management is <strong>operative vaginal delivery</strong> (eg, vacuum-assisted) to expedite delivery.&nbsp; Other indications for operative vaginal delivery include <strong>maternal exhaustion</strong>, fetal distress, and maternal conditions in which the Valsalva maneuver is not recommended (eg, hypertrophic cardiomyopathy).</p><p><strong>(Choice A)</strong>&nbsp; Fundal pressure is external pressure applied to the most cephalad portion of the uterus, with force directed toward the maternal pelvis.&nbsp; This maneuver does not improve spontaneous vaginal delivery rates.</p><p><strong>(Choice B)</strong>&nbsp; Epidurals can lengthen the second stage, but they do not cause arrest or affect spontaneous vaginal delivery rates.&nbsp; In addition, appropriate analgesia is a prerequisite for operative vaginal delivery.</p><p><strong>(Choice D)</strong>&nbsp; Internal podalic version is manual rotation of an infant to a breech presentation for breech vaginal delivery.&nbsp; Internal podalic version of a singleton fetus is contraindicated because breech vaginal delivery has a high risk of neonatal mortality and morbidity.</p><p><strong>(Choice E)</strong>&nbsp; The ideal fetal head position is occiput anterior (OA) because the flexed head presents a smaller diameter and facilitates the cardinal movements of labor.&nbsp; In contrast, the <a href=\"22287\">occiput posterior (OP) position</a> presents a larger-diameter head in a deflexed position.&nbsp; Rotating the fetal head to OP decreases the chance for spontaneous vaginal delivery.</p><p><strong>Educational objective:</strong><br>Second stage arrest of labor is lack of fetal descent after &#8805;4 hours of pushing in a primigravida with an epidural (&#8805;3 hours without) or &#8805;3 hours in a multigravida with an epidural (&#8805;2 hours without).&nbsp; Second-stage arrest is managed with operative vaginal delivery (eg, vacuum-assisted).&nbsp; Other indications for operative vaginal delivery include maternal exhaustion, fetal distress, and maternal conditions in which the Valsalva maneuver is not recommended.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23791,
            "topic": "Labor management",
            "titleId": 23791,
            "title": "Labor management",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Apply uterine fundal pressure",
                    "choiceNumber": 1,
                    "correctTaken": 2971,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decrease epidural infusion rate",
                    "choiceNumber": 2,
                    "correctTaken": 2443,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform vacuum-assisted vaginal delivery",
                    "choiceNumber": 3,
                    "correctTaken": 9661,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend internal podalic version",
                    "choiceNumber": 4,
                    "correctTaken": 352,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rotate fetal head to occiput posterior position",
                    "choiceNumber": 5,
                    "correctTaken": 1424,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29781504",
                    "mediaDataId": 0,
                    "title": "Epidural versus non-epidural or no analgesia for pain management in labor.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29781504",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28267223",
                    "mediaDataId": 0,
                    "title": "Fundal pressure during the second stage of labor.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28267223",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21099592",
                    "mediaDataId": 0,
                    "title": "Contemporary patterns of spontaneous labor with normal neonatal outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21099592",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 140,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16851,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 140,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 10995,
            "questionIndex": 12134,
            "questionText": "<p>A 38-year-old woman, gravida 7 para 6, at 37 weeks gestation comes to the office for a routine prenatal visit.&nbsp; For the past week, the patient has had leakage of clear fluid whenever she stands from a sitting position, forcing her to change her underwear twice daily.&nbsp; She has had no vaginal bleeding or contractions.&nbsp; The patient did not experience similar leakage during her other pregnancies, all of which ended in uncomplicated term vaginal deliveries.&nbsp; During this pregnancy, she was treated for chlamydia at 10 weeks gestation.&nbsp; Blood pressure is 110/70 mm Hg and weight is 105 kg (231.5 lb).&nbsp; Fetal heart rate is 150/min.&nbsp; Speculum examination shows a slightly open cervix and a scant amount of clear fluid in the posterior vagina, but no fluid emerges from the cervix when the patient coughs.&nbsp; The vaginal fluid does not turn nitrazine paper blue; a dried smear shows no ferning on microscopy.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"19801\" src=\"https://www.uworld.com/media/L45078.jpg\" ></p><p>Vaginal wetness or <strong>leakage of fluid</strong> in pregnancy may be due to a variety of causes.&nbsp; The most concerning is loss of amniotic fluid (eg, labor, intraamniotic infection); therefore, all pregnant patients with leakage of fluid require evaluation for prelabor rupture of membranes (PROM).&nbsp; PROM typically causes a large gush of fluid but may also cause vaginal wetness or intermittent leakage of small volumes.&nbsp; Confirmation is usually with visualization of amniotic fluid emerging from the cervix with Valsalva (eg, cough), nitrazine-positive testing (ie, turns blue), and/or ferning on microscopy.&nbsp; However, none of these signs are seen in this patient, making PROM unlikely <strong>(Choice C)</strong>.</p><p>A more likely cause of leakage of fluid in this patient is <strong>stress urinary incontinence</strong> (SUI), the <strong>involuntary leakage of urine</strong> with increased intraabdominal pressure (eg, standing from a sitting position, laughing).&nbsp; SUI is the most common type of urinary incontinence during pregnancy, due to decreased pelvic floor muscle and urethral sphincter strength as well as increased bladder pressure from the fetal presenting part and the weight of the gravid uterus.&nbsp; A small <strong>pool of urine in the posterior vagina</strong> may be seen on speculum examination because urine can become trapped in the vagina (ie, <strong>retrograde vaginal voiding</strong>) during pregnancy due to effects of the growing uterus and positional changes while voiding.</p><p><strong>(Choices A, B, and D)</strong>&nbsp; Patients with bacterial vaginosis and trichomoniasis can have intermittent leakage of fluid from vaginal discharge; however, speculum examination typically shows a discharge that is gray and malodorous (bacterial vaginosis) or green/yellow and frothy (trichomoniasis).&nbsp; Speculum examination of symptomatic patients with chlamydia typically shows mucopurulent cervical discharge.</p><p><strong>(Choice F)</strong>&nbsp; <a href=\"4908\">Vesicovaginal fistula</a> is a pathological communication between the bladder and vagina that is usually a sequela of gynecologic surgery or prolonged labor.&nbsp; Vesicovaginal fistulas typically present with continuous, rather than intermittent, urinary leakage.</p><p><strong>Educational objective:</strong><br>Intermittent vaginal leakage or wetness may be present in patients with either prelabor rupture of membranes or stress urinary incontinence.&nbsp; Patients with these symptoms are likely experiencing stress urinary incontinence if no fluid emerges from the cervix on Valsalva maneuver and nitrazine and fern testing are negative.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 1315,
            "topic": "Urinary incontinence",
            "titleId": 1315,
            "title": "Urinary incontinence",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bacterial vaginosis",
                    "choiceNumber": 1,
                    "correctTaken": 857,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Chlamydia trachomatis</em> cervicitis",
                    "choiceNumber": 2,
                    "correctTaken": 1254,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prelabor rupture of membranes",
                    "choiceNumber": 3,
                    "correctTaken": 829,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trichomoniasis",
                    "choiceNumber": 4,
                    "correctTaken": 134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinary incontinence",
                    "choiceNumber": 5,
                    "correctTaken": 7763,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vesicovaginal fistula",
                    "choiceNumber": 6,
                    "correctTaken": 5830,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25262291",
                    "mediaDataId": 0,
                    "title": "Urinary incontinence during pregnancy.  Is there a difference between first and third trimester?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25262291",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29332252",
                    "mediaDataId": 0,
                    "title": "A review of the impact of pregnancy and childbirth on pelvic floor function as assessed by objective measurement techniques.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29332252",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23436035",
                    "mediaDataId": 0,
                    "title": "Stress urinary incontinence in pregnant women: a review of prevalence, pathophysiology, and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23436035",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 121,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 16667,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 47,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 121,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 2528,
            "questionIndex": 2528,
            "questionText": "<p>A 36-year-old woman, gravida 1 para 0, at 38 weeks gestation is brought to the emergency department due to sudden vaginal bleeding and severe lower abdominal pain.&nbsp; The patient had a prenatal course notable for diet-controlled gestational diabetes mellitus.&nbsp; An ultrasound at 20 weeks gestation showed normal fetal anatomy and a fundal placenta.&nbsp; The patient has a 5-pack-year smoking history and has been trying to quit.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 158/96 mm Hg, and pulse is 112/min.&nbsp; Physical examination shows uterine tenderness and moderate vaginal bleeding.&nbsp; Digital cervical examination shows cervical dilation at 3 cm with the fetus in vertex presentation at 0 station.&nbsp; Fetal heart tracing shows a heart rate of 140/min with accelerations and moderate variability.&nbsp; Contractions occur every 2 minutes and last for 20 seconds.&nbsp; Urinalysis shows 3+ protein.&nbsp; This patient is at greatest risk of developing which of the following complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32602\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Abruptio placentae </strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition </strong></p></td><td><ul><li>Placental detachment from the uterus before fetal delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Hypertension, preeclampsia</li><li>Abdominal trauma</li><li>Prior abruptio placentae &nbsp;</li><li>Cocaine &amp; tobacco use</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation </strong></p></td><td><ul><li>Sudden-onset vaginal bleeding &nbsp;</li><li>Abdominal or back pain</li><li>High-frequency, low-intensity contractions</li><li>Rigid, tender uterus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis </strong></p></td><td><ul><li>Clinical</li><li>Ultrasound: &plusmn; retroplacental hematoma &nbsp;</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications </strong></p></td><td><ul><li>Fetal hypoxia, preterm birth, mortality &nbsp;</li><li>Maternal hemorrhage, disseminated intravascular coagulation</li></ul></td></tr></tbody></table></div><p>This patient with severe abdominal pain and vaginal bleeding likely has <strong>abruptio placentae</strong>.&nbsp; <a href=\"1056\">Placental abruption</a> is retroplacental bleeding that occurs between the placenta and uterine decidua that causes placental detachment and <strong>vaginal bleeding</strong>.&nbsp; The accumulation of blood in this space causes increased intrauterine pressure (eg, lower abdominal and/or back pain); a <strong>firm, tender uterus</strong>; and <strong>high-frequency contractions</strong>.&nbsp; Preeclampsia (eg, hypertension, proteinuria) and tobacco use are risk factors.</p><p>Some cases of abruptio placentae are self-limited and clinically insignificant; however, as more of the placenta detaches, there is greater risk for maternal and fetal complications.&nbsp; Maternal complications include hemorrhage, hypovolemic shock, and <strong>disseminated intravascular coagulation</strong> (due to tissue factor released in response to decidual bleeding).&nbsp; Potential fetal complications include impaired perfusion (eg, abnormalities on fetal heart rate tracing if hypoperfusion persists and hypoxia develops) and fetal demise.</p><p><strong>(Choice B)</strong>&nbsp; A retained placenta occurs with <a href=\"2906\">placenta accreta</a>, which typically presents with postpartum bleeding due to failed placental detachment after fetal delivery.&nbsp; Common risk factors are prior uterine surgery and an anterior placenta, which are not present in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Septic shock can occur in patients with an intraamniotic infection (IAI), which typically presents with uterine tenderness.&nbsp; However, patients with IAI typically have fever, fetal tachycardia, and malodorous vaginal discharge, none of which are seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"4363\">Umbilical cord prolapse</a> occurs when the umbilical cord delivers through the cervix ahead of the presenting fetal part.&nbsp; Risk factors include malpresentation (eg, breech) and an unengaged fetal presenting part (eg, severe polyhydramnios).&nbsp; In this patient, the fetal vertex is at 0 station (well engaged in the pelvis), making cord prolapse unlikely to occur.</p><p><strong>(Choice E)</strong>&nbsp; <a href=\"1057\">Uterine rupture</a> can cause acute abdominal pain and vaginal bleeding.&nbsp; It typically occurs in laboring patients with prior uterine surgery (eg, cesarean delivery), uterine overdistension (eg, twin gestation), or tetanic contractions (eg, oxytocin use).&nbsp; It is unlikely to occur in this patient with no risk factors.</p><p><strong>Educational objective:</strong><br>Abruptio placentae is the premature separation of the placenta from the uterine decidua prior to fetal delivery.&nbsp; It typically presents with painful vaginal bleeding; a firm, tender uterus; and high-frequency contractions.&nbsp; Complications include maternal hemorrhage, hypovolemic shock, and disseminated intravascular coagulation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14133,
            "topic": "Antepartum bleeding",
            "titleId": 14133,
            "title": "Antepartum bleeding",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Disseminated intravascular coagulation",
                    "choiceNumber": 1,
                    "correctTaken": 10139,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retained placenta",
                    "choiceNumber": 2,
                    "correctTaken": 1719,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Septic shock",
                    "choiceNumber": 3,
                    "correctTaken": 512,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Umbilical cord prolapse",
                    "choiceNumber": 4,
                    "correctTaken": 1326,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine rupture",
                    "choiceNumber": 5,
                    "correctTaken": 2888,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21241259",
                    "mediaDataId": 0,
                    "title": "Placental abruption: epidemiology, risk factors and consequences.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21241259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 16584,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 81,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 17104,
            "questionIndex": 18555,
            "questionText": "<p>A 28-year-old woman with sickle cell disease undergoes an induction of labor and has a spontaneous vaginal delivery.&nbsp; After delivery of the placenta, the patient begins to have heavy vaginal bleeding and passage of large, fist-sized clots.&nbsp; She is administered a high-dose oxytocin infusion and multiple uterotonic agents but continues to bleed heavily.&nbsp; Ten minutes later, the patient suddenly develops shortness of breath and chest pain.&nbsp; Blood pressure is 70/40 mm Hg, pulse is 118/min, and respirations are 28/min.&nbsp; Cardiac examination shows sinus tachycardia.&nbsp; Respiratory examination reveals tachypnea but clear lung bases.&nbsp; The uterus is soft and distended above the umbilicus, and the patient continues to have profuse vaginal bleeding.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">6 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">80,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">8,200/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">3.3 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Direct bilirubin</td><td style=\"vertical-align:middle;\">0.4 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Coagulation studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;International Normalized Ratio (INR)</td><td style=\"vertical-align:middle;\">1.6</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Prothrombin time</td><td style=\"vertical-align:middle;\">17 sec</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Activated PTT</td><td style=\"vertical-align:middle;\">53 sec</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s acute decompensation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t50322\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Disseminated intravascular coagulation</strong></p></td></tr><tr><td><p align=\"center\"><strong>Major causes</strong></p></td><td><ul><li>Sepsis</li><li>Severe traumatic injury</li><li>Malignancy</li><li>Obstetric complications</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Procoagulant excessively triggers coagulation cascade &rarr;</li><li>Formation of fibrin-/platelet-rich thrombi &amp; fibrinolysis &rarr;</li><li>Bleeding &amp; organ damage (eg, kidneys, lungs)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Thrombocytopenia</li><li>Prolonged PT &amp; PTT</li><li>&darr; Fibrinogen</li><li>&uarr; D-dimer</li><li>Microangiopathic hemolytic anemia (schistocytes)</li></ul></td></tr></tbody></table></div><p>This acutely decompensating patient has most likely developed <strong>disseminated intravascular coagulation</strong> (DIC).&nbsp; Obstetric complications (eg, postpartum hemorrhage, placental abruption) are a major cause of DIC due to the large volume of bleeding associated with these conditions.</p><p>Significant bleeding can cause release of tissue factor (thromboplastin), which leads to uncontrolled activation of the coagulation cascade and a <strong>consumptive coagulopathy</strong>.&nbsp; This leads to the formation of fibrin- and platelet-rich thrombi, which consume platelets (ie, <strong>thrombocytopenia</strong>), coagulation factors (evidenced by <strong>prolonged PT/INR and PTT</strong>), and fibrinogen.&nbsp; Fibrinolysis is then triggered to degrade the clots, which elevates D-dimer (a fibrin degradation product) and depletes antithrombin and proteins C and S.&nbsp; This results in a paradoxical <strong>thrombosis</strong>, as in this patient who has developed symptoms of pulmonary embolus (eg, dyspnea, chest pain, tachypnea).&nbsp; The thrombi in the vasculature also often shear red blood cells, leading to a <strong>microangiopathic hemolytic anemia</strong> (evidenced by elevated total bilirubin levels).</p><p>Patients with DIC require emergency supportive care, including treatment of the underlying etiology (eg, uterine atony causing postpartum hemorrhage) and resuscitation with blood products (eg, packed red blood cells, fresh frozen plasma).</p><p><strong>(Choice B)</strong>&nbsp; Although patients with sickle cell disease may require chronic opioids to manage painful vasoocclusive episodes, opioid withdrawal typically presents with mydriasis, piloerection, and yawning, not thrombocytopenia or abnormal coagulation studies.</p><p><strong>(Choice C)</strong>&nbsp; Oxytocin toxicity can occur in patients with prolonged or high-dose oxytocin administration (eg, induction of labor, postpartum hemorrhage).&nbsp; However, these patients have severe hyponatremia and related neurologic symptoms (eg, headache, seizure), not thrombocytopenia or abnormal coagulation studies.</p><p><strong>(Choice D)</strong>&nbsp; Splenic sequestration crisis, a life-threatening complication of sickle cell disease, can cause acute anemia, thrombocytopenia, and hypovolemic shock due to splenic pooling of RBCs and platelets.&nbsp; However, this condition mainly affects children because adults with sickle cell disease are functionally asplenic due to recurrent splenic infarction.</p><p><strong>(Choice E)</strong>&nbsp; Thrombotic thrombocytopenic purpura causes microangiopathic hemolytic anemia and thrombocytopenia that can result in shortness of breathing and bleeding.&nbsp; However, it does not typically cause a consumptive coagulopathy; therefore, patients typically have normal coagulation studies.</p><p><strong>Educational objective:</strong><br>Significant obstetric bleeding (eg, postpartum hemorrhage) can cause disseminated intravascular coagulation.&nbsp; This condition typically presents with bleeding and/or thrombosis (eg, acute pulmonary embolus), thrombocytopenia, and prolonged PT and PTT.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4183,
            "topic": "Postpartum hemorrhage",
            "titleId": 4183,
            "title": "Postpartum hemorrhage",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Disseminated intravascular coagulation",
                    "choiceNumber": 1,
                    "correctTaken": 13873,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Opioid withdrawal",
                    "choiceNumber": 2,
                    "correctTaken": 9,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin toxicity",
                    "choiceNumber": 3,
                    "correctTaken": 363,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Splenic sequestration crisis",
                    "choiceNumber": 4,
                    "correctTaken": 1798,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thrombotic thrombocytopenic purpura",
                    "choiceNumber": 5,
                    "correctTaken": 705,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26444122",
                    "mediaDataId": 0,
                    "title": "Disseminated intravascular coagulation syndromes in obstetrics.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26444122",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25840271",
                    "mediaDataId": 0,
                    "title": "Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25840271",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 97,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16748,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 97,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 3269,
            "questionIndex": 3269,
            "questionText": "<p>A 32-year-old primigravida at 28 weeks gestation comes to the emergency department due to painful contractions that began 2 hours ago and are now occurring every 5 minutes.&nbsp; She has had no leakage of fluid or vaginal bleeding; fetal movement is normal.&nbsp; The patient was last seen in the office a few days ago for a routine prenatal visit; she had some increasing pelvic pressure, but her pregnancy has otherwise been uncomplicated.&nbsp; She has no chronic medical conditions, and her only medications are a daily prenatal vitamin and folate supplement.&nbsp; Temperature is 37 C (99 F), blood pressure is 114/60 mm Hg, and pulse is 80/min.&nbsp; The fetal heart rate tracing has moderate variability, multiple accelerations, and no decelerations.&nbsp; Tocodynamometry shows contractions every 5 minutes.&nbsp; On digital pelvic examination, the cervix is 3 cm dilated and 90% effaced with the fetus in vertex presentation.&nbsp; Betamethasone and indomethacin are administered.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"42620\" src=\"https://www.uworld.com/media/highresdefault/L68348.png\"  ></p><p>This patient with frequent, regular contractions causing cervical dilation and effacement at &lt;37 weeks gestation is in <strong>preterm labor</strong>.&nbsp; Management depends on gestational age, with more interventions required at earlier gestations due to greater neonatal morbidity and mortality.&nbsp; Patients <strong>at &lt;32 weeks gestation</strong> are very preterm and therefore require the following:</p><ul><li><p><strong>Corticosteroids</strong> (eg, betamethasone) to promote fetal lung maturity (ie, decrease the risk of neonatal respiratory distress syndrome).</p></li><li><p><strong>Penicillin</strong> to prevent vertical transmission of group B <em>Streptococcus</em> (GBS), which occurs more frequently at preterm gestations.&nbsp; Therefore, prophylaxis is required in all preterm patients with an unknown or positive GBS status.</p></li><li><p><strong>Tocolysis</strong> (ie, contraction inhibition) to temporarily delay delivery and allow time for other interventions.&nbsp; <strong>Indomethacin</strong> is the first-line treatment at &lt;32 weeks gestation because of its high efficacy and few maternal adverse effects; as gestational age increases, however, indomethacin poses greater fetal risks (eg, premature closure of the ductus arteriosus).&nbsp; Therefore, nifedipine is preferred between 32 and 34 weeks gestation <strong>(Choice B)</strong>.</p></li><li><p><strong>Magnesium sulfate</strong> to decrease the risk of cerebral palsy, which is highest in infants delivered at &lt;32 weeks gestation.&nbsp; The neuroprotective mechanism of magnesium sulfate likely is due to stabilization of fetal neuronal membranes in utero or anti-inflammatory effects.&nbsp; Magnesium sulfate is not typically administered for fetal neuroprotection at &#8805;32 weeks gestation because of limited data that it prevents cerebral palsy at later gestational ages.</p></li></ul><p><strong>(Choice C)</strong>&nbsp; Observation and repeat cervical examination are appropriate management for suspected false labor (eg, irregular contractions with no cervical dilation) but inappropriate for active preterm labor.</p><p><strong>(Choice D)</strong>&nbsp; Progesterone therapy (intramuscular or vaginal) may decrease the rates of preterm delivery in patients with prior preterm delivery or an incidental short cervix (ie, &#8804;2.5 cm on ultrasound).&nbsp; It likely works by decreasing prostaglandin production, thereby maintaining uterine muscle relaxation.&nbsp; However, it cannot halt active preterm labor because it has no acute tocolytic effect.</p><p><strong>(Choice E)</strong>&nbsp; Sonographic cervical length measurement can be used to triage patients with preterm contractions because shorter lengths correlate with increased risk for preterm delivery.&nbsp; However, testing would not change management for this patient who is already high risk based on her clinical presentation (eg, cervical dilation and effacement).</p><p><strong>Educational objective:</strong><br>Patients in preterm labor at &lt;32 weeks gestation require corticosteroids, penicillin, tocolysis, and magnesium sulfate to decrease neonatal morbidity and mortality associated with preterm delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4239,
            "topic": "Preterm labor",
            "titleId": 4239,
            "title": "Preterm labor",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate",
                    "choiceNumber": 1,
                    "correctTaken": 9215,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nifedipine",
                    "choiceNumber": 2,
                    "correctTaken": 1373,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation only and repeat cervical examination in 2 hours",
                    "choiceNumber": 3,
                    "correctTaken": 4046,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progesterone",
                    "choiceNumber": 4,
                    "correctTaken": 1192,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ultrasound to measure cervical length",
                    "choiceNumber": 5,
                    "correctTaken": 879,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21575805",
                    "mediaDataId": 0,
                    "title": "Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21575805",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 151,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 16705,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 151,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 17662,
            "questionIndex": 19122,
            "questionText": "<p>A 42-year-old woman comes to the office after a positive home pregnancy test.&nbsp; The patient has a history of irregular menses and had a positive home pregnancy test after she went 6 months without a menstrual period.&nbsp; Her medical conditions include chronic hypertension, for which she takes multiple medications, and type 2 diabetes mellitus, for which she stopped taking metformin a few months ago due to side effects.&nbsp; BMI is 38 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Temperature is 37.6 C (100 F), blood pressure is 138/88 mm Hg, and pulse is 90/min.&nbsp; The abdomen is soft and without rebound or guarding.&nbsp; The uterus is nontender and fundal height measures 24 cm.&nbsp; Ultrasound findings show a singleton fetus at 24 weeks gestation with bilateral small, underdeveloped kidneys and a bladder with minimal urine.&nbsp; The amniotic fluid index is 4 cm (normal: &gt;5 cm).&nbsp; Which of the following is the most likely cause of this fetal presentation?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"44458\" src=\"https://www.uworld.com/media/L69724.jpg\" ></p><p>This patient&#39;s prenatal ultrasound shows bilateral small, underdeveloped fetal kidneys consistent with <strong>fetal renal hypoplasia</strong>.&nbsp; These fetal findings, in addition to the patient&#39;s history of chronic hypertension managed with multiple medications, are likely due to maternal use of an <strong>ACE inhibitor</strong> or <strong>angiotensin II receptor blocker</strong> (ARB), which are teratogens.</p><p>During pregnancy, angiotensin II is required for both fetal renal development and maintenance of fetal glomerular filtration rate.&nbsp; Both ACE inhibitors (which prevent the conversion of angiotensin I to II) and ARBs (which block angiotensin II at the angiotensin II receptor type 1) decrease angiotensin II activity, resulting in defects in fetal renal development (eg, renal hypoplasia, dysgenesis).&nbsp; Hypoplastic kidneys are unable to produce urine; therefore, fetal ultrasound typically reveals a <strong>small fetal bladder</strong> with <strong>minimal urine</strong>.&nbsp; The lack of urine production is exacerbated by a decreased fetal glomerular filtration rate, causing <strong>oligohydramnios</strong> (ie, amniotic fluid index &#8804;5 cm).&nbsp; Because amniotic fluid is required for fetal lung development and protection against limb compression, fetuses with severe oligohydramnios are also at risk for pulmonary hypoplasia and facial or limb defects (ie, <a href=\"5036\">Potter sequence</a>).</p><p>Because of these risks, women of childbearing age should not be started on ACE inhibitors or ARBs if other options are available.&nbsp; Those taking an ACE inhibitor or ARB should stop these medications prior to pregnancy.</p><p><strong>(Choice A)</strong>&nbsp; Autosomal recessive polycystic kidney disease can present with oligohydramnios; however, fetal ultrasound typically reveals bilaterally enlarged, cystic kidneys rather than renal hypoplasia.</p><p><strong>(Choice B)</strong>&nbsp; Chromosomal aneuploidy (eg, trisomy 18) is more common in women of advanced maternal age and can cause renal defects (eg, horseshoe kidney); however, fetuses typically have anomalies affecting multiple organ systems (eg, cardiac defects, omphalocele) rather than isolated renal hypoplasia.</p><p><strong>(Choice D)</strong>&nbsp; <a href=\"756\">Posterior urethral valves</a>, membranes obstructing the urethra, can cause oligohydramnios due to decreased fetal urine output.&nbsp; However, the backup of urine typically causes a distended fetal bladder and bilateral hydronephrosis.</p><p><strong>(Choice E)</strong>&nbsp; Uncontrolled pregestational diabetes mellitus typically causes cardiac (eg, septal defects, tetralogy of Fallot) and nervous system (eg, neural tube defects, sacral agenesis) defects that correlate with the severity of maternal hyperglycemia.&nbsp; Isolated fetal renal hypoplasia is uncommon.</p><p><strong>(Choice F)</strong>&nbsp; Vesicoureteral reflux, the retrograde travel of urine from the bladder to the ureter, typically causes enlarged fetal kidneys due to hydronephrosis.</p><p><strong>Educational objective:</strong><br>ACE inhibitors and angiotensin II receptor blockers are teratogens.&nbsp; The use of either medication during pregnancy can cause fetal renal hypoplasia (eg, bilateral, underdeveloped fetal kidneys) and oligohydramnios.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 9582,
            "topic": "Teratogens",
            "titleId": 9582,
            "title": "Teratogens",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autosomal recessive polycystic kidney disease",
                    "choiceNumber": 1,
                    "correctTaken": 934,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chromosomal aneuploidy",
                    "choiceNumber": 2,
                    "correctTaken": 826,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication exposure",
                    "choiceNumber": 3,
                    "correctTaken": 11440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Posterior urethral valves",
                    "choiceNumber": 4,
                    "correctTaken": 1502,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uncontrolled diabetes mellitus",
                    "choiceNumber": 5,
                    "correctTaken": 1811,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vesicoureteral reflux",
                    "choiceNumber": 6,
                    "correctTaken": 191,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "790",
                    "mediaDataId": 0,
                    "title": "Common teratogenic medications",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30371746",
                    "mediaDataId": 0,
                    "title": "The management of hypertension in women planning for pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30371746",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26254838",
                    "mediaDataId": 0,
                    "title": "Renin-angiotensin system blocker fetopathy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26254838",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 122,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16704,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 122,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 17124,
            "questionIndex": 18575,
            "questionText": "<p>A 40-year-old woman is evaluated on the labor and delivery unit for increasing shortness of breath and muscle weakness.&nbsp; Six hours ago, the patient had a spontaneous vaginal delivery at 38 weeks gestation.&nbsp; Immediately after delivery, she developed a blood pressure of 170/110 mm Hg with a headache and was diagnosed with preeclampsia with severe features.&nbsp; A magnesium sulfate infusion was initiated for seizure prophylaxis, and blood pressure improved with intermittent hypertensive therapy.&nbsp; Now, the patient reports difficulty breathing, flushing, and muscle weakness.&nbsp; She does not have chest pain or palpitations.&nbsp; The patient has no chronic medical conditions and has had no surgeries.&nbsp; Blood pressure is 144/84 mm Hg, pulse is 68/min, and respirations are 10/min.&nbsp; The patient appears drowsy and has difficulty keeping her eyes open.&nbsp; The lungs are clear to auscultation bilaterally.&nbsp; Deep tendon reflexes are absent.&nbsp; There is bilateral pitting edema up to the knees.&nbsp; Urine output is 50 mL over the past 3 hours.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42295\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Magnesium toxicity</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Mild: nausea, flushing, headache, hyporeflexia</li><li>Moderate: areflexia, hypocalcemia, somnolence</li><li>Severe: respiratory paralysis, cardiac arrest</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Stop magnesium therapy</li><li>Give IV&nbsp;calcium gluconate bolus</li></ul></td></tr></tbody></table></div><p>Magnesium sulfate is administered to patients with preeclampsia with severe features to prevent and treat eclamptic seizures.&nbsp; Magnesium acts as a calcium channel blocker on the CNS to raise the seizure threshold.&nbsp; However, with increasing serum levels, <strong>magnesium sulfate toxicity</strong> can develop.&nbsp; Patients may initially present with nausea, flushing, and hyporeflexia due to magnesium inhibition of presynaptic acetylcholine release (ie, neuromuscular inhibition).&nbsp; Further toxicity is uncommon in patients with normal renal function, but those with decreased urine output, such as this patient,&nbsp;are at a higher risk due to decreased urinary excretion of magnesium.</p><p>Therefore, magnesium toxicity can progress to cause further muscle weakness, loss of deep tendon reflexes (ie, <strong>areflexia</strong>), and <strong>respiratory depression</strong> (eg, drowsiness, respirations of 10/min).&nbsp; At severely high serum magnesium levels, patients are at risk for respiratory paralysis and cardiac arrhythmias.</p><p>Because of these life-threatening risks, patients treated with magnesium sulfate require close monitoring.&nbsp; Patients with signs of toxicity require a serum magnesium level and immediate <strong>cessation of magnesium sulfate</strong>.&nbsp; In addition, patients are administered <strong>calcium gluconate</strong>, which reverses neuromuscular paralysis, stabilizes cardiac membranes, and prevents cardiac arrest.</p><p><strong>(Choice B)</strong>&nbsp; Intravenous heparin infusions are used to manage an acute pulmonary embolus, which may present with dyspnea; however, these patients typically also have chest pain and tachypnea rather than respiratory depression.&nbsp; In addition, a pulmonary embolus is not associated with areflexia.</p><p><strong>(Choice C)</strong>&nbsp; Labetalol is administered to patients with preeclampsia and severely elevated blood pressures (eg, systolic &#8805;160 mm Hg or diastolic &#8805;110 mm Hg).&nbsp; This patient&#39;s blood pressure does not meet the criteria for acute therapy.</p><p><strong>(Choice D)</strong>&nbsp; Naloxone is used to reverse opioid toxicity, which can present with drowsiness and respiratory depression.&nbsp; However, deep tendon reflexes are typically preserved, making this diagnosis less likely in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Normal saline boluses may be used to treat decreased urine output due to hypovolemia (eg, acute blood loss).&nbsp; This patient&#39;s decreased urine output is most likely due to renal insufficiency associated with preeclampsia.&nbsp; In addition, fluid boluses increase the risk of pulmonary edema in patients with preeclampsia.</p><p><strong>Educational objective:</strong><br>Magnesium sulfate toxicity typically presents with signs of progressive neuromuscular inhibition (eg, areflexia, respiratory depression).&nbsp; Treatment is with cessation of magnesium sulfate and initiation of calcium gluconate to reverse neuromuscular paralysis and prevent cardiac arrest.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4219,
            "topic": "Preeclampsia",
            "titleId": 4219,
            "title": "Preeclampsia",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Calcium gluconate",
                    "choiceNumber": 1,
                    "correctTaken": 4220,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous heparin infusion",
                    "choiceNumber": 2,
                    "correctTaken": 202,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Labetalol",
                    "choiceNumber": 3,
                    "correctTaken": 134,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Naloxone",
                    "choiceNumber": 4,
                    "correctTaken": 102,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal saline bolus",
                    "choiceNumber": 5,
                    "correctTaken": 401,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26695587",
                    "mediaDataId": 0,
                    "title": "ACOG Committee opinion no 652: magnesium sulfate use in obstetrics.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26695587",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23383864",
                    "mediaDataId": 0,
                    "title": "An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23383864",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 5059,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 67,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 18430,
            "questionIndex": 19898,
            "questionText": "<p>A 27-year-old woman, gravida 3 para 2, at 37 weeks gestation is admitted to the labor and delivery unit in active labor.&nbsp; The patient has had no vaginal bleeding or leakage of fluid.&nbsp; She has no chronic medical conditions but has not received prenatal care during this pregnancy.&nbsp; Prior pregnancies were caesarean deliveries for fetal heart rate decelerations at term gestation.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/70 mm Hg, and pulse is 88/min.&nbsp; Ultrasonography reveals an anterior placenta and a breech fetus with a heart rate of 140/min.&nbsp; The patient undergoes a repeat cesarean delivery.&nbsp; After delivery of the infant, the uterine fundus is firm, but the placenta is densely adherent to the anterior uterine wall and cannot be removed.&nbsp; Vital signs are repeated, and temperature is 36.7 C (98.1 F), blood pressure is 114/66 mm Hg, and pulse is 83/min.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"1114\" src=\"https://www.uworld.com/media/highresdefault/L17624.jpg\"  ></p><p>This patient with dense placental adhesions to the anterior uterine wall has <strong>placenta accreta</strong>, or <strong>pathologic attachment of placental villi</strong> directly to the <strong>uterine myometrium</strong> rather than the uterine decidua (ie, uterine&nbsp;endometrium modified for pregnancy).&nbsp; This abnormal placentation likely occurs due to <strong>defective or absent endometrial decidualization</strong> in areas with scarring from prior uterine surgery (eg, cesarean delivery, dilation and curettage).&nbsp; The lack of normal decidua in these areas allows the chorionic villi to attach to the myometrium and become morbidly adherent.</p><p>Placenta accreta is typically diagnosed on routine second-trimester ultrasound, and management is usually with a planned cesarean hysterectomy (prior to the onset of spontaneous labor) due to the significant risk for postpartum hemorrhage.&nbsp; However, in some cases (eg, limited prenatal care), the diagnosis of placenta accreta is made only after fetal delivery, when there is significant <strong>difficulty detaching the placenta</strong> from the uterine wall.&nbsp; Attempts to remove the placenta (eg, manual placental extraction, sharp uterine curettage) are usually unsuccessful (due to dense adhesions between the placenta and uterus) and can significantly <strong>increase bleeding</strong>; therefore, removal of the placenta is contraindicated <strong>(Choices D and E)</strong>.</p><p>Without emergency management, placenta accreta can lead to severe postpartum hemorrhage, hemorrhagic shock, consumptive coagulopathy, and maternal death.&nbsp; Therefore, the best next step in management is <strong>surgical removal</strong> of the uterus (ie, <strong>hysterectomy</strong>) with the <strong>placenta in situ</strong> (ie, remaining attached to the uterine wall), which minimizes further maternal blood loss.</p><p><strong>(Choices A and C)</strong>&nbsp; Bimanual uterine massage and <a href=\"10672\">intrauterine balloon tamponade</a> are treatment options for postpartum hemorrhage due to uterine atony (ie, inadequate contractility).&nbsp; In contrast, this patient has a firm uterine fundus.&nbsp; In addition, neither intervention treats the underlying etiology of placenta accreta, which is a morbidly adherent placenta.</p><p><strong>Educational objective:</strong><br>Placenta accreta occurs due to direct placental villi attachment to the uterine myometrium.&nbsp; Patients typically have difficulty with placental detachment following fetal delivery and continued placental bleeding due to dense adhesions to the uterine wall.&nbsp; Treatment is with hysterectomy (with the placenta in situ) to prevent life-threatening maternal hemorrhage.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4163,
            "topic": "Placental accreta",
            "titleId": 4163,
            "title": "Placental accreta",
            "topicAttributeId": 330586,
            "topicAttribute": "Disorders of pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bimanual uterine massage",
                    "choiceNumber": 1,
                    "correctTaken": 1927,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hysterectomy with placenta in situ",
                    "choiceNumber": 2,
                    "correctTaken": 8117,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intrauterine balloon tamponade",
                    "choiceNumber": 3,
                    "correctTaken": 141,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Manual placental extraction",
                    "choiceNumber": 4,
                    "correctTaken": 4424,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sharp uterine curettage",
                    "choiceNumber": 5,
                    "correctTaken": 2014,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30461695",
                    "mediaDataId": 0,
                    "title": "Obstetric care consensus no. 7: placenta accreta spectrum.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30461695",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28599899",
                    "mediaDataId": 0,
                    "title": "Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28599899",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33204176",
                    "mediaDataId": 0,
                    "title": "Placenta accreta spectrum disorders: challenges, risks, and management strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33204176",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 54,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16623,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 54,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 4,
            "name": "CUSTOM"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}